About Resverlogix Corp. (TSE:RVX)
Resverlogix Corp. is a clinical-stage biotechnology company. The Company is a development-stage company, which is engaged in developing apabetalone (RVX-208), a first-in-class small molecule selective Bromodomain and ExtraTerminal domain (BET) inhibitor. Apabetalone is used for the treatment of patients with high-risk cardiovascular disease, (including peripheral arterial disease), diabetes mellitus, chronic kidney disease, Alzheimer's disease and orphan diseases. Apabetalone is being investigated in a Phase III clinical trial for the secondary prevention of major adverse cardiovascular events (MACE) in high risk patients with diabetes mellitus and chronic kidney disease. The Company initiated a Phase III clinical trial BETonMACE with apabetalone in high-risk cardiovascular disease patients with low high-density lipoprotein. It focuses on conducting a proof-of-concept clinical trial in patients with Paroxysmal Nocturnal Hemoglobinuria. The Company has not generated any revenues.
Industry, Sector and Symbol:
- Sector: Healthcare
- Industry: Biotechnology
- Sub-Industry: N/A
- Symbol: TSE:RVX
- CUSIP: N/A
- Web: www.resverlogix.com/
- Market Cap: C$163.91 million
- Outstanding Shares: 114,624,000
- 50 Day Moving Avg: C$1.49
- 200 Day Moving Avg: C$1.65
- 52 Week Range: C$1.23 - C$2.41
Sales & Book Value:
- Trailing P/E Ratio: N/A
- P/E Growth: 0.00
- Annual Revenue: N/A
- Price / Sales: N/A
- Book Value: C($1.00) per share
- Price / Book: -1.43
- EBITDA: ($35,430,000.00)
- Return on Assets: -602.93%
- Average Volume: 34,065 shs.
- Short Ratio: 4.05
Frequently Asked Questions for Resverlogix Corp. (TSE:RVX)
What is Resverlogix Corp.'s stock symbol?
Resverlogix Corp. trades on the Tornton Stock Exchange (TSX) under the ticker symbol "RVX."
When will Resverlogix Corp. make its next earnings announcement?
Who are some of Resverlogix Corp.'s key competitors?
Some companies that are related to Resverlogix Corp. include Anavex Life Sciences Corp. (AVXL), XOMA Corporation (XOMA), Osiris Therapeutics (OSIR), VBI Vaccines (VBIV), Protalix Biotherapeutics (PLX), ContraFect Corporation (CFRX), Trillium Therapeutics (TRIL), Concordia International Corp (CXR), Aevi Genomic Medicine (GNMX), Ohr Pharmaceuticals (OHRP), Can Fite Biopharma Ltd (CANF), Can Fite Biopharma Ltd (CANF), Soligenix (SNGX), Soligenix (SNGX), Mateon Therapeutics (MATN), Senesco Technologies (SVON), Windtree Therapeutics (WINT) and Affymax (AFFY).
Who are Resverlogix Corp.'s key executives?
Resverlogix Corp.'s management team includes the folowing people:
- Donald J. McCaffrey, Chairman of the Board, President, Chief Executive Officer, Secretary
- A. Brad Cann, Chief Financial Officer
- Jan O. Johansson M.D. Ph.D., Senior Vice President - Medical Affairs
- Kenneth Lebioda, Senior Vice President - Business & Corporate Development
- Michael T. Sweeney M.D., Senior Vice President - Clinical Development
- Norman Wong M.D., Chief Scientific Officer
- Eldon R. Smith M.D., Lead Director
- Norma K. Biln, Director
- Shawn Lu, Director
- Kelly B. McNeill, Independent Director
How do I buy Resverlogix Corp. stock?
Shares of Resverlogix Corp. and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.
What is Resverlogix Corp.'s stock price today?
MarketBeat Community Rating for Resverlogix Corp. (TSE RVX)MarketBeat's community ratings are surveys of what our community members think about Resverlogix Corp. and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of Resverlogix Corp. stock can currently be purchased for approximately C$1.43.
Consensus Ratings for Resverlogix Corp. (TSE:RVX) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||No ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Consensus Price Target: ||N/A|Consensus Price Target History for Resverlogix Corp. (TSE:RVX)
Analysts' Ratings History for Resverlogix Corp. (TSE:RVX)
No equities research coverage for this company has been tracked by MarketBeat.com
Earnings History for Resverlogix Corp. (TSE:RVX)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for Resverlogix Corp. (TSE:RVX)
2017 EPS Consensus Estimate: ($0.18)
2018 EPS Consensus Estimate: ($0.53)
(Data provided by Zacks Investment Research)
|Quarter||Number of Estimates||Low Estimate||High Estimate||Average Estimate|
Dividend History for Resverlogix Corp. (TSE:RVX)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Resverlogix Corp. (TSE:RVX)Insider Trades by Quarter for Resverlogix Corp. (TSE:RVX)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
Headline Trends for Resverlogix Corp. (TSE:RVX)
Latest Headlines for Resverlogix Corp. (TSE:RVX)
Resverlogix Corp. (RVX) Chart for Friday, October, 20, 2017